B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure
Top Cited Papers
- 21 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (20) , 2392-2397
- https://doi.org/10.1161/01.cir.0000016642.15031.34
Abstract
Background— Given the high incidence of sudden death in patients with chronic heart failure (CHF) and the efficacy of implantable cardioverter-defibrillators, an appropriate tool for the prediction...Keywords
This publication has 21 references indexed in Scilit:
- Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCHEuropean Journal of Heart Failure, 2002
- Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunctionJournal of the American College of Cardiology, 2001
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot studyJournal of the American College of Cardiology, 2001
- Meta-analysis of the implantable cardioverter defibrillator secondary prevention trialsEuropean Heart Journal, 2000
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Effects of mechano-electrical feedback: potential arrhythmogenic influence in patients with congestive heart failureCardiovascular Research, 1996
- Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1989
- Predictors of total mortality and sudden death in mild to moderate heart failureJournal of the American College of Cardiology, 1989
- Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overloadJournal of the American College of Cardiology, 1983